We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+28.85%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$117M
AUM Growth
+$5.01M
Cap. Flow
-$4.67M
Cap. Flow %
-3.97%
Top 10 Hldgs %
39.15%
Holding
85
New
22
Increased
25
Reduced
13
Closed
24

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.7M
2
INCY icon
Incyte
INCY
+$2.45M
3
SCTY
SolarCity Corporation
SCTY
+$2.25M
4
INSY
Insys Therapeutics, Inc.
INSY
+$1.98M
5
LVS icon
Las Vegas Sands
LVS
+$1.97M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.91M
2
TCS
THE CONTAINER STORE GROUP, INC.
TCS
+$3M
3
MEG
Media General, Inc
MEG
+$2.88M
4
GENT
GENTIUM SPA ADS
GENT
+$2.63M
5
LNKD
LinkedIn Corporation
LNKD
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 36.91%
2 Industrials 12.76%
3 Communication Services 12.13%
4 Technology 6.3%
5 Materials 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AWAY
26
DELISTED
HOMEAWAY INC COM
AWAY
$1.88M 1.6%
50,000
+2,500
+5% +$106K
ANAC
27
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$1.86M 1.58%
92,900
+35,900
+63% +$696K
AGN
28
DELISTED
Allergan Inc
AGN
$1.74M 1.48%
14,000
-11,000
-44% -$1.34M
VCYT icon
29
Veracyte
VCYT
$3.7B
$1.73M 1.48%
101,200
+15,975
+19% +$255K
MNDT
30
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.69M 1.44%
27,501
+5,651
+26% +$401K
LCI
31
DELISTED
Lannett Company, Inc.
LCI
$1.66M 1.41%
+11,625
New +$1.8M
IWM icon
32
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$1.59M 1.36%
+13,700
New +$1.58M
CTSH icon
33
Cognizant
CTSH
$24.9B
$1.56M 1.33%
30,900
+2,900
+10% +$145K
EVHC
34
DELISTED
Envision Healthcare Holdings Inc
EVHC
$1.56M 1.32%
15,364
+7,849
+104% +$785K
ITMN
35
DELISTED
INTERMUNE INC
ITMN
$1.51M 1.28%
+45,000
New +$1M
BOBE
36
DELISTED
Bob Evans Farms, Inc.
BOBE
$1.5M 1.27%
29,925
+4,425
+17% +$219K
GOGO icon
37
Gogo Inc
GOGO
$565M
$1.48M 1.26%
72,000
+19,000
+36% +$419K
DATA
38
DELISTED
Tableau Software, Inc.
DATA
$1.45M 1.23%
19,000
+9,800
+107% +$825K
AMRI
39
DELISTED
Albany Molecular Research Inc
AMRI
$1.39M 1.18%
+74,500
New +$1.03M
FRX
40
DELISTED
FOREST LABORATORIES INC
FRX
$1.25M 1.06%
13,500
+10,500
+350% +$847K
TWX
41
DELISTED
Time Warner Inc
TWX
$1.24M 1.06%
+19,817
New +$1.24M
PBYI icon
42
Puma Biotechnology
PBYI
$404M
$1.18M 1.01%
11,350
+8,450
+291% +$993K
NFLX icon
43
Netflix
NFLX
$299B
$1.06M 0.9%
210,000
-420,000
-67% -$2.41M
BMY icon
44
CALL
Bristol-Myers Squibb
BMY
$133B
$1.04M 0.88%
+20,000
New +$1.06M
AGIO icon
45
Agios Pharmaceuticals
AGIO
$1.79B
$1.03M 0.88%
+26,250
New +$878K
HHH icon
46
Howard Hughes
HHH
$3.81B
$885K 0.75%
6,504
-5,507
-46% -$692K
RLYP
47
DELISTED
RELYPSA INC COM
RLYP
$820K 0.7%
27,500
-5,500
-17% -$199K
ZLTQ
48
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$784K 0.67%
40,000
-74,000
-65% -$1.44M
DDD icon
49
PUT
3D Systems Corp
DDD
$431M
$651K 0.55%
+11,000
New +$820K
VNDA icon
50
Vanda Pharmaceuticals
VNDA
$307M
$618K 0.53%
+38,000
New +$540K
1
2
3 4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Atika Capital Management held 85 positions worth $117M, up 4.5% from $112M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Atika Capital Management withdrew a net $4.67M in Q1 2014, closing 24 positions and reducing 13 holdings. Its most notable exit was Gilead Sciences, an estimated $3.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 28% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Atika Capital Management opened a new position in Biogen worth $2.6M.

  • Atika Capital Management's largest Q1 2014 buy was Biogen: 8,500 shares worth $2.6M.
  • Atika Capital Management added most to Incyte in Q1 2014, an estimated $2.45M increase.
  • Atika Capital Management's biggest Q1 2014 reduction was Netflix, cutting an estimated $2.41M.
  • Atika Capital Management fully exited Gilead Sciences in Q1 2014, selling an estimated $3.91M.
  • Atika Capital Management's ten largest holdings make up 39% of its $117M portfolio in Q1 2014.
  • Atika Capital Management opened 22 new positions and closed 24 in Q1 2014.
  • Atika Capital Management's portfolio value rose 4.5% quarter-over-quarter to $117M.

Based on Atika Capital Management's 13F filing for Q1 2014, filed 15 May 2014.